TNDMTandem Diabetes Care, Inc.
Price
+28%1YEnd-of-day closes, not the intraday tick.
Survival is the story here: start there
Quality mixed, hard red flags, growth steady, the market against it.
Tandem Diabetes Care is a global leader in insulin delivery and diabetes technology, specializing in the design, development, and commercialization of advanced solutions that reduce the burden of diabetes management. We serve nearly 500,000 people living with diabetes in more than 25 countries worldwide. Our strategy is to offer flexibility and choice in intelligent insulin delivery systems through an accessible portfolio of market-leading pumps, applications and insights.
In the company’s own words · 10-K filed Feb 19, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Tandem Diabetes Care, Inc. (TNDM) reported revenue of $255M in Q2 2026 (quarter ended Jun 30, 2026), up 5.8% from the same quarter a year earlier. That came with a gross margin of 57% and net loss of $21M. For the full year FY2025, revenue was $1.01B (+7.9% year on year) and net income −$205M. Its largest product in Q2 2026 was Supplies And Other at $140M, 55% of the disclosed total, ahead of Pump at 45%. The next results filing is expected around Nov 5, 2026, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Aug 6, 2026Tandem Diabetes Care Announces Second Quarter 2026 Financial Results.Earnings release · press release
- May 21, 2026At the Annual Meeting, the Company’s stockholders also approved the Company’s 2023 Long-Term Incentive Plan, as amended, to, among other things, increase the number of shares of the Company’s common stock (Common Stock) authorized for issuance under the plan by 3,260,000 shares (as so amended, the Amended Plan)Shareholder rights modified · Form 8-K
- May 15, 2026On May 11, 2026, Mark Novara, the Executive Vice President and Chief Commercial Officer of Tandem Diabetes Care, Inc. (the “Company”), was notified that his employment with the Company is being terminated without cause.Director or officer change · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Business segments
Jun 2026 · $254.6MThe company’s own SEC segment disclosure.
- Supplies And Other$139.9M55%
- Pump$114.7M45%
Why these answers
Each answer with the checks it was read from. Open one for the numbers.
Conflicts between checks are named, never averaged, and thin data says so.